サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439243

埋込型輸液ポンプの世界市場：洞察、競合情勢、市場予測：2030年

Implantable Infusion Pumps - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
埋込型輸液ポンプの世界市場：洞察、競合情勢、市場予測：2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の埋込型輸液ポンプの市場規模は、2024年から2030年までの予測期間中に5.6％のCAGRで拡大すると予測されています。埋込型輸液ポンプの需要は、主に、糖尿病、がん、慢性疼痛、および高齢者人口の負担の増加と相まって、人口の間で他の様々な障害の有病率の増加、先端技術の統合、埋込型薬物輸液ポンプの新製品イノベーションに向けた政府および民間メーカーによる投資の増加、および障害の適切な管理に関する啓発プログラムの上昇などに関連しています。

埋込型輸液ポンプの普及率の上昇は、埋込型輸液ポンプの需要を加速させるとみられています。国際糖尿病連合（International Diabetes Federation 2021）が発表したデータによると、世界全体で20～79歳の成人の約5億3,700万人が糖尿病を患っており、この数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると推定されています。

加えて、がん、痙縮、肺動脈性肺高血圧症などの治療に用いる体内埋込型輸液ポンプに関する政府のガイドラインが登場しており、予測期間中に市場が拡大する可能性が高いです。例えば、2020年10月、UniCareは、長期的、継続的、または断続的な薬剤注入を目的とした埋込型輸液ポンプの使用に対処するガイドラインを発表しました。したがって、前述の要因は世界の埋込型輸液ポンプ市場の成長に寄与すると思われます。

当レポートでは、世界の埋込型輸液ポンプ市場について調査し、市場の概要とともに、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 埋込型輸液ポンプ市場レポートのイントロダクション

第2章 埋込型輸液ポンプ市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 埋込型輸液ポンプ市場の主な要因分析

  • 埋込型輸液ポンプ市場の促進要因
  • 埋込型輸液ポンプ市場の抑制要因と課題
  • 埋込型輸液ポンプ市場機会

第5章 埋込型輸液ポンプにおけるポーターのファイブフォース分析

第6章 埋込型輸液ポンプ市場の概要

  • 用途別
  • エンドユーザー別
  • 地域別

第7章 埋込型輸液ポンプの企業と製品プロファイル

  • Medtronic
  • Intera Oncology
  • FLOWONIX MEDICAL INC
  • Tandem Diabetes Care, Inc.

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Implantable Infusion Pump Market in Global (2021-2030)
  • Table 3: Implantable Infusion Pump Market in Global by Application (2021-2030)
  • Table 4: Implantable Infusion Pump Market in Global by End-User (2021-2030)
  • Table 5: Implantable Infusion Pump Market in Global by Geography (2021-2030)
  • Table 6: Implantable Infusion Pump Market in North America (2021-2030)
  • Table 7: Implantable Infusion Pump Market in the US (2021-2030)
  • Table 8: Implantable Infusion Pump Market in Canada (2021-2030)
  • Table 9: Implantable Infusion Pump Market in Mexico (2021-2030)
  • Table 10: Implantable Infusion Pump Market in Europe (2021-2030)
  • Table 11: Implantable Infusion Pump Market in France (2021-2030)
  • Table 12: Implantable Infusion Pump Market in Germany (2021-2030)
  • Table 13: Implantable Infusion Pump Market in the United Kingdom (2021-2030)
  • Table 14: Implantable Infusion Pump Market in Italy (2021-2030)
  • Table 15: Implantable Infusion Pump Market in Spain (2021-2030)
  • Table 16: Implantable Infusion Pump Market in Rest of Europe (2021-2030)
  • Table 17: Implantable Infusion Pump Market in Asia-Pacific (2021-2030)
  • Table 18: Implantable Infusion Pump Market in China (2021-2030)
  • Table 19: Implantable Infusion Pump Market in Japan (2021-2030)
  • Table 20: Implantable Infusion Pump Market in India (2021-2030)
  • Table 21: Implantable Infusion Pump Market in Australia (2021-2030)
  • Table 22: Implantable Infusion Pump Market in South Korea (2021-2030)
  • Table 23: Implantable Infusion Pump Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Implantable Infusion Pump Market in the Rest of the World (2021-2030)
  • Table 25: Implantable Infusion Pump Market in the Middle East (2021-2030)
  • Table 26: Implantable Infusion Pump Market in Africa (2021-2030)
  • Table 27: Implantable Infusion Pump Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Implantable Infusion Pump Market in Global (2021-2030)
  • Figure 3: Implantable Infusion Pump Market in Global by Application (2021-2030)
  • Figure 4: Implantable Infusion Pump Market in Global by End-User (2021-2030)
  • Figure 5: Implantable Infusion Pump Market in Global by Geography (2021-2030)
  • Figure 6: Implantable Infusion Pump Market in North America (2021-2030)
  • Figure 7: Implantable Infusion Pump Market in the US (2021-2030)
  • Figure 8: Implantable Infusion Pump Market in Canada (2021-2030)
  • Figure 9: Implantable Infusion Pump Market in Mexico (2021-2030)
  • Figure 10: Implantable Infusion Pump Market in Europe (2021-2030)
  • Figure 11: Implantable Infusion Pump Market in France (2021-2030)
  • Figure 12: Implantable Infusion Pump Market in Germany (2021-2030)
  • Figure 13: Implantable Infusion Pump Market in the United Kingdom (2021-2030)
  • Figure 14: Implantable Infusion Pump Market in Italy (2021-2030)
  • Figure 15: Implantable Infusion Pump Market in Spain (2021-2030)
  • Figure 16: Implantable Infusion Pump Market in Rest of Europe (2021-2030)
  • Figure 17: Implantable Infusion Pump Market in Asia-Pacific (2021-2030)
  • Figure 18: Implantable Infusion Pump Market in China (2021-2030)
  • Figure 19: Implantable Infusion Pump Market in Japan (2021-2030)
  • Figure 20: Implantable Infusion Pump Market in India (2021-2030)
  • Figure 21: Implantable Infusion Pump Market in Australia (2021-2030)
  • Figure 22: Implantable Infusion Pump Market in South Korea (2021-2030)
  • Figure 23: Implantable Infusion Pump Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 24: Implantable Infusion Pump Market in the Rest of the World (2021-2030)
  • Figure 25: Implantable Infusion Pump Market in the Middle East (2021-2030)
  • Figure 26: Implantable Infusion Pump Market in Africa (2021-2030)
  • Figure 27: Implantable Infusion Pump Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities
  • Figure 31: PORTER's Five Force Analysis
目次
Product Code: DIMDCL0030

Implantable Infusion Pump Market By Application (Chronic Pain, Diabetes, Oncology, and Others], End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 due to rising prevalence of various chronic disorders and rising investment towards new product innovations

The global Implantable Infusion Pump market will grow at a CAGR of 5.6% during the forecast period from 2024 to 2030. The demand for implantable infusion pumps is primarily associated with the growing prevalence of various disorders such as diabetes, cancer, chronic pain, and various other disorders among the population coupled with the growing burden of the old age population, integration of advanced technology, increasing investments by government and private manufacturers towards new product innovations in implantable drug infusion pumps, and rising awareness programs regarding proper management of disorders, among others.

Implantable Infusion Pump Market Dynamics:

The rising prevalence of implantable infusion pumps is going to accelerate the demand for implantable infusion pumps. As per the data published by the International Diabetes Federation 2021, globally around 537 million adults aged between 20 and 79 years have diabetes and this number is estimated to rise to 643 million by 2030 and 783 million by 2045.

Implantable insulin pumps which are a type of implantable infusion pump are used to deliver insulin in the peritoneal cavity which has a rich supply of blood vessels and can therefore absorb insulin very efficiently. Thereby raising the demand for implantable infusion pumps.

In addition, emerging guidelines from the government concerning an implantable infusion pump for the treatment of cancer, spasticity, and pulmonary arterial hypertension, are likely to augment the market during the forecasted period. For instance, in October 2020, UniCare published the guideline addressing the use of implantable infusion pumps, intended to provide long-term, continuous, or intermittent drug infusion. Hence, the aforementioned factors will contribute to the global implantable infusion pump market growth.

However, certain factors such as stringent regulatory approval process and medication errors while drug delivery are likely to pose a minor hurdle for the growth of the implantable infusion pump market.

Global Implantable Infusion Pump Segment Analysis:

Implantable Infusion Pump by Application (Chronic Pain, Diabetes, Oncology, and Others], End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Implantable Infusion Pump application segment, Oncology is expected to hold the largest share of the implantable infusion pumps. This is owing to the rising cases of cancer among the population worldwide.

The study conducted by the International Agency for Research on Cancer mentioned that worldwide, an estimated 19.3 million new cancer cases were reported in 2020.

According to the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

Also, as per Global Cancer Observatory 2021 data, globally around 544,352 cases of Non-Hodgkin lymphoma and 83,087 cases of Hodgkin lymphoma were reported in 2020. As per the same source globally around 474,519 leukemia cases and nearly 176,404 cases of multiple myeloma were reported in 2020.

The data published by Global Cancer Observatory (2023) says that globally around 1.41 million new cases of prostate cancer were reported in 2020 and by 2040 this number is expected to reach 2.24 million.

Therefore, rising cases of cancer across the globe can boost the market for implantable infusion pump devices.

North America Is Expected To Dominate The Overall Implantable Infusion Pump Market:

Among all the regions, North America is expected to dominate the overall Implantable Infusion Pump market during the forecast period. This domination is due to the growing prevalence of chronic diseases, and access to better healthcare infrastructure coupled with the presence of major market players in the region. Also, the supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.

Further, In the United States, the rising prevalence of chronic pain is expected to fuel the market for implantable infusion pumps. According to CDC 2020 data, in 2019, 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities (referred to as high-impact chronic pain) and both increased with age and were highest among adults aged 65 and over.

Thus rising chronic pain cases are expected to raise the demand for implantable infusion pumps as these are surgically implanted to provide continuous drug delivery for pain management in patients with non-cancer pain.

Moreover, recent product approval by the US regulatory body Food and Drug Administration is also expected to bolster the market for implantable infusion pumps in the region. For instance, recently in May 2020, Medtronic received pre-market approval from the US FDA for SynchroMed II Implantable Infusion Pump and Implantable System for Remodulin.

Hence, the above-mentioned factors are expected to drive the implantable infusion pump market during the forecasted period.

Implantable Infusion Pump Market Key Players:

Some of the key market players operating in the Implantable Infusion Pump market include Medtronic; Intera Oncology, FLOWONIX MEDICAL INC, Tandem Diabetes Care, Inc., and others.

Recent Developmental Activities in Implantable Infusion Pump Market:

In February 2020, Flowonix received FDA approval to market Prometra® II Pump for use with Intrathecal Baclofen.

Key Takes Away from the Implantable Infusion Pump Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Implantable Infusion Pump Market.

Various opportunities available for the other competitor in the Implantable Infusion Pump Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for implantable infusion pump market growth in the coming future?

Target Audience who can be benefited from Implantable Infusion Pump Market Report Study

Implantable Infusion Pump providers

Research organizations and consulting companies

Implantable Infusion Pump-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in implantable infusion pump

Various End-Users who want to know more about the implantable infusion pump market and the latest technological developments in the implantable infusion pump market.

Frequently Asked Questions for Implantable Infusion Pumps Market:

1. What are Implantable Infusion Pumps Market?

Implantable infusion pumps are small devices that are implanted beneath the skin via surgery to deliver liquid pain medication to a specific area of your body via a tiny, flexible tube (catheter). Infusion pumps can deliver precise and constant pain relief medication.

2. What is the market for global implantable infusion pumps?

The global implantable infusion pump market will grow at a CAGR of 5.6% during the forecast period from 2024 to 2030.

3. What are the drivers for global implantable infusion pumps market?

The major drivers driving the demand for implantable infusion pumps are the rowing prevalence of various disorders such as diabetes, cancer, chronic pain, and various other disorders among the population coupled with the growing burden of the old age population, integration of advanced technology, increasing investments by government and private manufacturers towards new product innovations in implantable drug infusion pumps, and rising awareness programs regarding proper management of disorders, among others.

4. What are the key players operating in global implantable infusion pumps market?

Some of the key market players operating in the Implantable Infusion Pump market include Medtronic; Intera Oncology, FLOWONIX MEDICAL INC, Tandem Diabetes Care, Inc., and others.

5. Which region has the highest share in the implantable infusion pumps market?

North America is anticipated to dominate the overall implantable infusion pumps market during the forecast period, 2024-2030 due to the improved healthcare infrastructure, and favorable reimbursement scenario in the region. Moreover, recent product approvals and the presence of key manufacturers are also factors contributing to the highest market share.

Table of Contents

1. Implantable Infusion Pump Market Report Introduction

2. Implantable Infusion Pump Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Implantable Infusion Pump Market Key Factors Analysis

  • 4.1. Implantable Infusion Pump Market Drivers
    • 4.1.1. Increase in the incidence rate of cancer, diabetes, and other chronic disorders
    • 4.1.2. Increasing investments by government and private manufacturers toward new product innovations in implantable drug infusion pumps
    • 4.1.3. Integration of advanced technology
    • 4.1.4. Rising awareness programs regarding the proper management of disorders
  • 4.2. Implantable Infusion Pump Market Restraints and Challenges
    • 4.2.1. Fewer Product Recalls
    • 4.2.2. Medication error while drug delivery
  • 4.3. Implantable Infusion Pump Market Opportunities
    • 4.3.1. Growth opportunities in the treatment of inflammatory diseases
    • 4.3.2. Growth Opportunities in Emerging Nations

5. Implantable Infusion Pump Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Implantable Infusion Pump Market layout

  • 6.1. By Application
    • 6.1.1. Chronic Pain
    • 6.1.2. Diabetes
    • 6.1.3. Oncology
    • 6.1.4. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals
    • 6.2.2. Ambulatory Surgical Centers
    • 6.2.3. Home Care Settings
    • 6.2.4. Others
  • 6.3. By Geography
    • 6.3.1. North America Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Implantable Infusion Pump Market Size in USD million (2021-2030)
    • 6.3.2. Europe Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.2.1. France Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Implantable Infusion Pump Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.3.1. China Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.3.3. India Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia Pacific Implantable Infusion Pump Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Implantable Infusion Pump Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Implantable Infusion Pump Market Size in USD million (2021-2030)

7. Implantable Infusion Pump Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Intera Oncology
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. FLOWONIX MEDICAL INC
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Tandem Diabetes Care, Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us